Results 21 to 30 of about 84,689 (291)

The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. [PDF]

open access: yesPLoS ONE, 2012
The molecular chaperone Hsp90 orchestrates regulatory circuitry governing fungal morphogenesis, biofilm development, drug resistance, and virulence. Hsp90 functions in concert with co-chaperones to regulate stability and activation of client proteins ...
Rebecca S Shapiro   +4 more
doaj   +1 more source

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans

open access: yesmBio, 2023
Resistance to fluconazole (FLC), the most widely used antifungal drug, is typically achieved by altering the azole drug target and/or drug efflux pumps. Recent reports have suggested a link between vesicular trafficking and antifungal resistance.
Juliana Rizzo   +16 more
doaj   +1 more source

Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1

open access: yesmSphere, 2021
Overexpression of the fungal pleiotropic drug resistance (PDR) transporter Cdr1 is a major cause of antifungal drug resistance in Candida ...
Golnoush Madani   +2 more
doaj   +1 more source

Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review

open access: yesAntibiotics, 2023
Fungal infections are becoming one of the main causes of morbidity and mortality in people with weakened immune systems. Mycoses are becoming more common, despite greater knowledge and better treatment methods, due to the regular emergence of resistance ...
Ali A. Rabaan   +19 more
doaj   +1 more source

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

open access: yesAntibiotics, 2020
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs), along with significant agricultural crop loss caused by various fungal species, has resulted in the widespread use of antifungal agents.
Amir Arastehfar   +8 more
doaj   +1 more source

Antifungal resistance in dermatology

open access: yesIndian Journal of Dermatology, 2018
Cutaneous fungal infections affect more than one-fourth of world's population. The pathogenesis and severity of fungal infection depend on various immunological and nonimmunological factors.
Varadraj Pai   +2 more
doaj   +1 more source

Fungal biofilm resistance [PDF]

open access: yes, 2012
Fungal biofilm infections have become increasingly recognised as a significant clinical problem. One of the major reasons behind this is the impact that these have upon treatment, as antifungal therapy often fails and surgical intervention is required ...
Ramage, Gordon   +7 more
core   +1 more source

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens [PDF]

open access: yesJournal of Fungi, 2020
Human fungal pathogens are attributable to a significant economic burden and mortality worldwide. Antifungal treatments, although limited in number, play a pivotal role in decreasing mortality and morbidities posed by invasive fungal infections (IFIs). However, the recent emergence of multidrug-resistant Candida auris and Candida glabrata and acquiring
Amir Arastehfar   +7 more
openaire   +5 more sources

The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi

open access: yesMicroorganisms, 2023
The mortality rates of invasive fungal infections remain high because of the limited number of antifungal drugs available and antifungal drug resistance, which can rapidly evolve during treatment.
Kylie J. Boyce
doaj   +1 more source

Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance

open access: yesJournal of Infection and Public Health, 2023
In recent years, we are facing the challenge of drug resistance emergence in fungi. The availability of limited antifungals and development of multi-drug resistance in fungal pathogens has become a serious concern in the past years in the health sector ...
Ali A. Rabaan   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy